Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1GEH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,075
Award facts
- Contract value 100% obligated
- $18,074.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $18,074.64, was awarded on January 8, 2026, to Amerisourcebergen Drug Corp (a subsidiary of parent company Cencora, Inc.) for the supply of Dupixent 300 mg/2 ml pens. The award was made by the Defense Logistics Agency under a firm fixed-price contract type with no set-aside designation, indicating full and open competition. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 9, 2026. This delivery order is issued under Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor specializing in supplying a diverse range of brand-name and generic medications, vaccines, and medical supplies to federal military and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates its established capability to deliver specialty pharmaceuticals across multiple therapeutic domains on a competitive basis. Dupixent, an immunosuppressant medication commonly used in dermatology and allergic conditions, is consistent with the types of specialty medications the company routinely supplies through its federal contracts, reinforcing its role as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F1GEH?
SPE2DR26F1GEH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F1GEH worth?
The government has obligated $18,075 on SPE2DR26F1GEH.
Is contract SPE2DR26F1GEH an order under another contract?
Yes. SPE2DR26F1GEH is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GEH competed?
The extent of competition for SPE2DR26F1GEH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award